EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Multilevel Intervention and Human Papillomavirus Vaccination Disparities

Wei Yi Kong, Lila J Finney Rutten, Jeph Herrin, Jennifer L St Sauver, Gregory D Jenkins, Joan M Griffin, Robert M Jacobson

JAMA Network Open · 07.07.2025 · 8 (7) · e2518895

DOI: 10.1001/jamanetworkopen.2025.18895 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 07.07.2025. Verfasst von Wei Yi Kong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Healthcare Disparities, Papillomavirus Infections, Papillomavirus Vaccines, Vaccination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Uptake of human papillomavirus (HPV) vaccination varies by characteristics, exposing some children to higher HPV cancer risks than others.

Objective

To examine whether the effectiveness of a multilevel intervention on HPV vaccination differed by race and ethnicity, rurality, and Area Deprivation Index (ADI) in children ages 11 to 12 years. Design, Setting, and Participants A stepped-wedge cluster randomized trial was conducted from April 2018 to August 2022 among children at 6 Mayo Clinic primary care practices in Minnesota to improve HPV vaccination. This secondary analysis was performed from March to June 2024.

Intervention

A multilevel intervention that included parent reminder/recall letters, which alerted parents of children due or past due for vaccination, and health care professional audit/feedback reports, which alerted health care professionals of their own vaccination rates. Main Outcome and Measure Vaccine initiation (first dose of the 2-dose HPV vaccine) and vaccine completion (second dose) were the primary study outcomes. In this secondary analysis, the effect of the intervention on HPV vaccine initiation and completion by race and ethnicity, rurality, and ADI quartiles (Qs) was assessed.

Results

A total of 6232 children aged 11 to 12 years (3285 [52.7%] male; 3481 [55.9%] aged 11 years and 2751 [44.1%] aged 12 years) were included in the analysis. Of the study participants, 304 (4.9%) were Asian, 561 (9.0%) Black, 146 (2.3%) Hispanic, 4501 (72.2%) White, and 720 (11.6%) other, including American Indian or Alaskan Native, Native Hawaiian or Pacific Islander, Other Pacific Islander, Samoan, unable to provide, unknown, chose not to disclose, or other unspecified. A total of 5434 participants (87.2%) were urban residents, and 2794 (44.8%) resided in ADI Q2 areas. With usual care, HPV vaccine initiation and completion rates were significantly lower with each increasing ADI quartile (initiation: Cochran-Armitage test for trend [SE], −0.02 [0.01]; P < .001; completion: Cochran-Armitage test for trend [SE], −0.05 [0.01]; P < .001) but did not differ by children’s race and ethnicity or rurality. With the intervention, vaccine initiation increased significantly for most children (range of rates, 9.2% [95% CI, 5.2%-13.3%] to 24.0% [95% CI, 7.5%-40.6%]) except those with Black race, in rural settings, and in ADI Q4 (highest area deprivation); vaccine completion increased significantly for most children (range of rates, 19.4% [95% CI, 5.5%-33.3%] to 31.2% [95% CI, 12.1%-50.3%]) except for those in ADI Q4. Conclusions and Relevance In this secondary analysis of a cluster randomized trial, a multilevel intervention was associated with increased HPV vaccination for most children but had limited effect for those residing in areas of highest deprivation. Future research should explore other intervention strategies that would effectively promote HPV vaccination among families in socioeconomically disadvantaged areas to reduce HPV vaccination disparities. Trial Registration ClinicalTrials.gov Identifier: NCT03501992

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Healthcare DisparitiesPapillomavirus InfectionsPapillomavirus VaccinesVaccinationChildFemaleHumansMaleEthnicityHuman Papillomavirus VirusesMinnesotaParentsRacial GroupsSecondary Data Analysis

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Division of Epidemiology, Mayo Clinic, Rochester, Minnesota.
  • Division of Community Internal Medicine, Geriatrics, and Palliative Care, Mayo Clinic, Rochester, Minnesota.
  • Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Flying Buttress Associates, Charlottesville, Virginia.
  • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
  • Division of Health Care Delivery Research and Robert D. and Patricia E. Kern Center for Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.

Förderung

  • NCI NIH HHS

Zitieren

APA

Kong, W. Y., Finney Rutten, L. J., Herrin, J., St Sauver, J. L., Jenkins, G. D., Griffin, J. M., & Jacobson, R. M. (2025). Multilevel Intervention and Human Papillomavirus Vaccination Disparities. JAMA Network Open, 8(7), e2518895. https://doi.org/10.1001/jamanetworkopen.2025.18895

Vancouver

Kong WY, Finney Rutten LJ, Herrin J, St Sauver JL, Jenkins GD, Griffin JM, et al. Multilevel Intervention and Human Papillomavirus Vaccination Disparities. JAMA Network Open. 2025;8(7):e2518895. doi:10.1001/jamanetworkopen.2025.18895

BibTeX
@article{Kong2025,
  author = {Kong, Wei Yi and Finney Rutten, Lila J and Herrin, Jeph and St Sauver, Jennifer L and Jenkins, Gregory D and Griffin, Joan M and Jacobson, Robert M},
  title = {Multilevel Intervention and Human Papillomavirus Vaccination Disparities},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {7},
  pages = {e2518895},
  doi = {10.1001/jamanetworkopen.2025.18895}
}
Kostenlos starten →